New Atopy Claim for Cortavance with up to 28 Days Use!

Virbac is pleased to announce that Cortavance, the potent topical steroid containing HCA, for the symptomatic treatment of inflammatory and pruritic skin disorders in dogs now provides a first line choice for the potent local control of the symptoms associated with atopy.

Virbac Supports WVI African Painted Dog Conservation Project

Virbac are pleased to confirm their continued support to Wildlife Vets International in their campaign to reduce the risk of population decline in the African painted dog due to disease.

What Can Pet Owners Do at Home to Contribute to the Successful Management of Skin Disease?

Vets are very fortunate to have some outstanding medicines to treat the aetiology and clinical signs of atopy, giving both the pet and the owner relief from the angst of allergic skin disease. However, it is easy to overlook the value of topical therapies and simple environmental management routines, which can play an important role in managing the condition whilst also helping to cultivate client relationships.